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Abstract The contractile function of striated muscle cells
is altered by oxidative/nitrosative stress, which can be
observed under physiological conditions but also in dis-
eases like heart failure or muscular dystrophy. Oxidative
stress causes oxidative modifications of myofilament pro-
teins and can impair myocyte contractility. Recent evi-
dence also suggests an important effect of oxidative stress
on muscle elasticity and passive stiffness via modifications
of the giant protein titin. In this review we provide a short
overview of known oxidative modifications in thin and
thick filament proteins and then discuss in more detail
those oxidative stress-related modifications altering titin
stiffness directly or indirectly. Direct modifications of titin
include reversible disulfide bonding within the cardiac-
specific N2-Bus domain, which increases titin stiffness, and
reversible S-glutathionylation of cryptic cysteines in
immunoglobulin-like domains, which only takes place after
the domains have unfolded and which reduces titin stiff-
ness in cardiac and skeletal muscle. Indirect effects of
oxidative stress on titin can occur via reversible modifi-
cations of protein kinase signalling pathways (especially
the NO-cGMP-PKG axis), which alter the phosphorylation
level of certain disordered titin domains and thereby
modulate titin stiffness. Oxidative stress also activates
proteases such as matrix-metalloproteinase-2 and (indi-
rectly via increasing the intracellular calcium level) cal-
pain-1, both of which cleave titin to irreversibly reduce
titin-based stiffness. Although some of these mechanisms
require confirmation in the in vivo setting, there is evidence
that oxidative stress-related modifications of titin are rel-
evant in the context of biomarker design and represent
potential targets for therapeutic intervention in some forms
of muscle and heart disease.
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Introduction: Oxidative stress as an important modifier
of myocyte properties
Oxidative stress occurs in the cell when reactive oxygen/
nitrogen species (ROS/RNS) are increased or when the
antioxidant defence mechanisms are decreased; i.e., when
one or both of these factors go out of balance. Under
pathological conditions, ROS can react with and thereby
damage DNA, lipids and proteins, initiating tissue damage
and cell death. However, at physiological concentrations,
ROS can be critical regulators of cellular signalling path-
ways. ROS/RNS are increased, e.g., in myocardial ische-
mia/reperfusion (I/R) injury (Canton et al. 2004), in the
course of heart failure (Haywood et al. 1996; Sawyer et al.
2002; Canton et al. 2011), and in various muscular dys-
trophies, such as dysferlinopathy (Terrill et al. 2013),
Duchenne muscular dystrophy (DMD), and the mdx mouse
model of DMD (Haycock et al. 1996; Disatnik et al. 1998;
Kim et al. 2013; Canton et al. 2014). Among the targets of
oxidative modification are various contractile and regula-
tory proteins of the sarcomeres, the structural and func-
tional units of striated muscle. Oxidative modification of
these myofilament proteins can have dramatic functional
consequences, including altered calcium sensitivity of
force production, contractile impairment and muscle
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weakness (Andrade et al. 2001; Smith and Reid 2006;
Lamb and Westerblad 2011; Balogh et al. 2014), and
sometimes also improvements in cardiac or skeletal muscle
function (Gao et al. 2012; Lovelock et al. 2012; Mollica
et al. 2012).
Important sources of ROS in striated muscle cells
(Fig. 1) include xanthine oxidase (XO) (Baldus et al.
2006), NADPH oxidases (Nox) (Heymes et al. 2003),
uncoupled endothelial nitric oxide synthase (eNOS) (Xia
et al. 1998), inducible nitric oxide synthase (iNOS) (Shah
and MacCarthy 2000) as well as neuronal nitric oxide
synthase (nNOS) (Zhang et al. 2014), and mitochondrial
enzymes such as respiratory chain complex I or III and
monoamine oxidase (MAO) (St-Pierre et al. 2002; Di Lisa
et al. 2009). Well-known examples of ROS/RNS are
hydrogen peroxide (H2O2), hydroxyl radicals (OH),
superoxide anions (O2
-), and the highly reactive perox-
ynitrite (ONOO-), which is formed in the reaction of nitric
oxide (NO) and O2
- (Fig. 1). Antioxidant defense
mechanisms are also in place, involving enzymes such as
catalase and superoxide dismutase (SOD), the thioredoxin
system, as well as non-enzymatic factors like vitamins E
and C (Fig. 1). ROS/RNS can alter miscellaneous cellular
properties by reacting with amino acids in proteins. These
proteins are then modified either reversibly (i.e., the oxi-
dized protein can be enzymatically repaired) or irreversibly
(i.e., the oxidized protein must be replaced by de novo
synthesis), depending on the nature and amount of ROS
(Canton et al. 2014). Reversible modifications caused by
ROS/RNS include disulfide bridge formation, S-glutath-
ionylation, nitrosylation, and sulfenylation; irreversible
modifications include sulfinylation, sulfonylation, nitration,
and carbonylation (Canton et al. 2014; Steinberg 2013).
Frequent targets of oxidative modification are the thiol-
containing amino acids, cysteine and methionine. Nitration
affects predominantly tyrosine residues, whereas the main
targets of carbonylation are lysine, arginine, threonine, and
proline (Canton et al. 2014). Some of the modifications
Fig. 1 Schematic overview of important sources and targets of
oxidative stress, as well as protectors against it, in striated muscle
cells. Sources of reactive oxygen/nitrogen species include xanthine
oxidase (XO), NADPH oxidases (Nox), uncoupled endothelial nitric
oxide synthase (eNOS), inducible nitric oxide synthase (iNOS),
neuronal nitric oxide synthase (nNOS), and mitochondrial factors
such as complex I or III and monoamine oxidase (MAO). Antioxidant
enzymes include superoxide dismutase (SOD), catalase, and thiore-
doxins, whereas non-enzymatic antioxidants are vitamins C and E.
Oxidative stress damages DNA, lipids, and proteins, and among
others, causes oxidation of myofilament proteins and alterations to the
ratio between oxidized (GSSG) and reduced forms (GSH) of
glutathione. Among the sarcomere proteins biochemically modified
by oxidative stress are actin, tropomyosin (Tm), troponin I (TnI) and
troponin C (TnC), myosin light chains 1 and 2 (MLC1 and MLC2),
myosin heavy chain (MHC), myosin-binding protein-C (MyBP-C),
and titin
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greatly impact protein structure and function, whereas for
other modifications, the functional implications are
incompletely understood or unknown. The reversibility of
oxidative modifications can play a role in signal trans-
duction processes and may also have a protective effect on
the protein.
In this review we focus exclusively on the role of oxi-
dative stress in altering the properties and functions of
myofilament proteins. We begin with a brief overview of
known oxidative modifications in thin and thick filament
proteins, before discussing recent evidence for oxidative
modifications of the giant titin filament, the protein
responsible for the elasticity of cardiac and skeletal myo-
cytes. We also touch on the pathophysiological implica-
tions of these findings and the potential for biomarker use
and therapeutic intervention in disease. Overall, we make a
case for the emerging importance of oxidative modifica-
tions of the titin springs in regulating myocyte elasticity
and ‘passive’ stiffness under oxidative stress conditions.
Impact of oxidative stress on thin filament proteins
Various myofilament proteins are biochemically and
functionally altered under oxidative stress. Among these
proteins are the components that constitute the sarcomeric
thin filaments, actin, tropomyosin, and subunits of troponin
(Fig. 1). Mass spectrometry identified actin among the S-
thiolated cardiomyocyte proteins showing increased abun-
dance in rat hearts following I/R (Eaton et al. 2002). Fur-
thermore, S-glutathionylation of actin at Cys374 occurred
already at baseline but was substantially elevated under
ischemic conditions, and this oxidation impaired the
interaction between actin and tropomyosin and the poly-
merisation of G-actin to F-actin (Dalle-Donne et al. 2003;
Chen and Ogut 2006; Passarelli et al. 2010). S-glutath-
ionylation of actin also reduced the activity of the acto-
myosin S1-ATPase (Pizarro and Ogut 2009). Additionally,
carbonylation of actin caused disruption of the actin fila-
ments in vitro (Dalle-Donne et al. 2001). Actin carbonyl-
ation was increased in end-stage failing human hearts and
correlated with contractile impairment and reduced car-
diomyocyte viability (Canton et al. 2011). Moreover,
increased carbonylation of actin and other myofilament
proteins was shown to be associated with a reduced
Ca2?-sensitivity of force production in infarcted mouse
hearts (Balogh et al. 2014).
Oxidation of the regulatory protein tropomyosin in
microembolized pig hearts decreased contractile function,
and this decrease correlated with the formation of tropo-
myosin homodimers (Canton et al. 2006). Tropomyosin
dimer formation due to disulfide bonding was also detected
in mouse cardiac tissue following myocardial infarction
(Avner et al. 2012), in isolated rat hearts after postischemic
reperfusion (Canton et al. 2004), and in failing rabbit hearts
exposed to elevated oxidative stress caused by rapid left
ventricular pacing (Heusch et al. 2010). Additionally,
tropomyosin formed disulfide bridges with actin in H2O2-
perfused rat hearts (Canton et al. 2004). Nitroxyl (HNO), a
RNS activating signalling pathways different from NO
(Miranda 2005), caused the formation of actin-tropomyosin
heterodimers via actin Cys257 and tropomyosin Cys190
(Gao et al. 2012), which probably added to the beneficial
effects on myocardial contractile function observed with
HNO (Gao et al. 2012; Sabbah et al. 2013; Arcaro et al.
2014). In skeletal myocytes from the mdx mouse model of
DMD, ROS production as well as the overall content of
oxidized thiols were increased in comparison to wildtype
animals, and tropomyosin cross-linking occurred (Menazza
et al. 2010; El-Shafey et al. 2011). Nitration of tropomy-
osin was shown to occur in aging rat skeletal muscles
(Kanski et al. 2005b).
The cardiac troponin subunits, cTnI and cTnC, contain
tyrosine residues which are targets of nitration in aging rat
hearts (Kanski et al. 2005a), although the functional impact
from this biochemical modification is not known. The TnI
isoform from fast-twitch skeletal muscle was identified as a
target of S-glutathionylation in rat and human, and this
modification increased the Ca2? sensitivity of the con-
tractile apparatus (Mollica et al. 2012). In this TnI isoform,
Cys133 was the only accessible cysteine. Since the phos-
phorylation of a homologous serine in cTnI impedes the
interaction with cTnC (Ward et al. 2001), oxidation of
Cys133 in fast-twitch muscle TnI may also lead to a reduced
binding affinity to TnC (Mollica et al. 2012).
Taken together, an established effect of oxidative
modifications in thin filament proteins is the reduced
myofilament Ca2?-sensitivity of force production (although
this parameter can transiently increase under oxidative
stress), which depresses contractile performance in both
cardiac and skeletal muscle (Lamb and Westerblad 2011;
Steinberg 2013). Oxidative stress-related effects on the
structure of thin filament components and on the actin-
myosin interface presumably contribute to the contractile
impairment. In some cases, the contractile activity can be
improved under oxidizing conditions (Steinberg 2013).
Impact of oxidative stress on thick filament proteins
Thick filament proteins impaired by oxidative modifica-
tions include the myosin light chains 1 and 2 (MLC1 and
MLC2), myosin heavy chain (MHC), and cardiac myosin-
binding protein-C (cMyBP-C). As regards MLC1 and
MLC2, tyrosine nitration (Tyr73 and Tyr185 in MLC1, and
Tyr182 in MLC2) promoted the degradation of these
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proteins by matrix metalloproteinase-2 (MMP-2) (Dor-
oszko et al. 2010; Polewicz et al. 2011). Nitrotyrosine-
containing sequences from MLC were also detected in
aging skeletal muscle (Kanski et al. 2005b). Oxidation of
sulfhydryl groups in cysteines or methionines of MLC1
reduced the contractile force of human cardiomyocytes
(Hertelendi et al. 2008).
MyBP-C appears to be modified by oxidative stress in
various ways (Brennan et al. 2006). The protein showed
similar levels of carbonylation in normal and infarcted
mouse hearts (Balogh et al. 2014). Reversible S-glutath-
ionylation of MyBP-C could be induced in detergent-
extracted cardiac fibres in vitro by treatment with oxidized
glutathione (GSSG) or reducing agent, dithiothreitol
(DTT), and the sites of S-glutathionylation in MyBP-C
were identified as Cys479, Cys627, and Cys655 (Patel et al.
2013). These oxidative modifications resulted in enhanced
myofilament Ca2? sensitivity and diastolic dysfunction
(Lovelock et al. 2012; Patel et al. 2013).
MHC was found to be nitrated at several different
tyrosine residues (Tyr114, Tyr116, Tyr134, and Tyr142) in
aging rat heart (Hong et al. 2007) and increased MHC
nitration negatively influenced the force generation of rat
ventricular trabeculae (Mihm et al. 2003). Peroxynitrite-
induced oxidation of two cysteines in MHC (Cys697 and
Cys707) close to the catalytic centre inhibited the activity of
the skeletal muscle S1-ATPase and reduced the maximum
force (Tiago et al. 2006). Furthermore, in infarcted mouse
hearts, the levels of MHC carbonylation were increased,
which was suggested to partly explain the contractile
impairment of these hearts (Balogh et al. 2014). Treatment
of cardiomyocytes with HNO induced cross-bridge for-
mation between cysteines of MHC and MLC1, and this
modification was associated with an improved contractility
(Gao et al. 2012). In conclusion, an increasing number of
oxidative modifications are known to affect the major thick
filament proteins, frequently with negative (but sometimes
with positive) consequences for cardiomyocyte contractil-
ity. Oxidative modification can also predispose some thick
filament proteins to increased degradation.
Regulation of muscle elasticity via modifications of titin
For the remainder of the review, we focus on the titin
protein chain, the ‘third’ filament of the sarcomere next to
the thin and thick filaments, and we begin with a brief
discussion of some relevant titin properties (for a more
comprehensive recent review, see Linke and Hamdani
2014). A well-established function of titin is to help
determine the elastic properties of cardiac and skeletal
muscles and to generate a ‘passive’ force upon stretching.
The elasticity of titin resides within the extensible I-band
portion of the protein, which is differentially spliced, giv-
ing rise to the major titin isoforms termed N2BA and N2B
(both expressed in cardiac muscle) and N2A (expressed in
skeletal muscle). I-band titin is composed of ‘proximal’,
‘middle’, and ‘distal’ (relative to the Z-disk) immuno-
globulin-like (Ig-)domain regions; the PEVK domain rich
in proline, glutamate, valine, and lysine, which is a disor-
dered region; the N2-A element; and the cardiac-specific
N2-B element, which contains a large disordered segment,
the N2B-unique sequence (N2-Bus) (Fig. 2). The Ig-
domain regions and the disordered segments are all
involved in the molecular mechanism of titin elasticity
(Linke 2000; Linke and Fernandez 2002; Li et al. 2002).
Titin stiffness is regulated in various different ways. In
the long-term, the titin isoform size and variant can be
altered (‘isoform switch’), which greatly affects myocyte
passive stiffness. In the perinatal heart, a transition occurs
from a highly compliant, fetal N2BA isoform (3.7 MDa) to
shorter/less compliant N2BA isoforms and the short/stiff
N2B titin (Lahmers et al. 2004; Opitz et al. 2004; Warren
et al. 2004). This isoform transition can partially be
reversed in the failing human heart, where the N2BA:N2B
expression ratio increases again (Neagoe et al. 2002;
Makarenko et al. 2004). In the short-term, titin stiffness is
regulated by post-translational modifications (Linke and
Hamdani 2014). Phosphorylation of the N2-Bus or the
PEVK domain is mediated, e.g., by protein kinase (PK)A,
cyclic guanosine monophosphate (cGMP) activated PKG,
PKCa, or calcium/calmodulin-dependent protein kinase II
(CaMKII), and these modifications—with the exception of
the PKCa-mediated phosphorylation—decrease titin-based
stiffness (Yamasaki et al. 2002; Kru¨ger and Linke 2006;
Kru¨ger et al. 2009; Hidalgo et al. 2009; Hamdani et al.
2013c). In human heart failure, a phosphorylation deficit
was observed, especially for PKG-mediated titin phos-
phorylation, and this was correlated with increased myo-
cardial stiffness (Kru¨ger et al. 2009; Ko¨tter et al. 2013).
Additional means by which titin stiffness can be modulated
are now emerging, and these mechanisms are triggered by
oxidative stress. The main purpose of this review is to
discuss how ROS/RNS can modify the titin springs via
different pathways, which can have opposing effects on the
protein’s stiffness.
Hypo-phosphorylation of titin due to impaired NO/
cGMP/PKG signalling
NO produced by NOS enzymes (Fig. 1) activates soluble
guanylyl cyclase (sGC) by binding to its heme moiety. The
sGC then increases cGMP production and thereby activates
PKG. This signalling mechanism is impaired by oxidative
stress. Under oxidant conditions, eNOS becomes
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uncoupled by direct S-glutathionylation or via depletion of
the enzyme’s co-factor, tetrahydrobiopterin, which
decreases NO but increases the production of the highly
reactive superoxide anion, O2
- (De Pascali et al. 2014).
The lowered NO bioavailability reduces sGC activation
and depresses the cGMP-PKG pathway. Moreover, the
ferrous heme iron Fe2? can be oxidized to Fe3? under
oxidative stress, further reducing the activity of sGC
(Schrammel et al. 1996).
Due to the impaired NO/cGMP/PKG signalling under
oxidizing conditions, titin may become hypo-phosphory-
lated mainly at the N2-Bus, which would increase the
stiffness of the titin spring (Fig. 2a). Evidence that these
alterations are presumably important in heart disease
comes from the following observations: (i) a PKG-
dependent titin phosphorylation deficit exists in failing
human hearts, along with increased passive stiffness
(Kru¨ger et al. 2009; Ko¨tter et al. 2013); (ii) a reduced
myocardial cGMP concentration and PKG activity can be
found in human and canine diastolic heart failure (van
Heerebeek et al. 2012; Hamdani et al. 2013a); and (iii)
increased nitrotyrosine levels are detectable in the hearts
of diastolic heart failure patients (van Heerebeek et al.
2012). Furthermore, the pathologically high passive
stiffness can be corrected ex vivo by administering
cGMP-PKG to isolated cardiomyocytes (Borbe´ly et al.
2009; van Heerebeek et al. 2012; Hamdani et al. 2013a;
Hamdani et al. 2013b) and in vivo by boosting the cGMP-
PKG pathway through pharmacological interventions in
the dogs with diastolic heart failure (Bishu et al. 2011).
These findings suggest that oxidative/nitrosative stress
increases cardiac titin stiffness by impairing upstream
Fig. 2 Oxidative stress-related modifications of titin affecting titin-
based passive stiffness. The top panel illustrates the different
segments of the titin chain (N2BA isoform) in a half-sarcomere,
focusing on the various regions making up the elastic I-band segment.
Segments where oxidative modifications occur are marked by arrows;
the letters correspond to the respective type of oxidative modification
indicated in panels (a–d). a Oxidative stress induces hypo-phosphor-
ylation of the titin N2-Bus as it impairs NO-cGMP-PKG signalling;
this modification increases titin stiffness. b Oxidizing conditions
promote the formation of disulfide bonds in the titin N2-Bus; this
modification increases titin stiffness. c Under oxidative conditions,
buried cysteines in titin immunoglobulin (Ig-)domains are S-glutath-
ionylated after they become exposed by domain unfolding (triggered
by sarcomere stretch); this modification prevents domain refolding
and thus reduces titin stiffness. d Oxidative stress increases the
activity of proteases such as matrix metalloproteinase-2 (MMP2) and
(via a rise in intracellular Ca2? concentration) calpain-1, which
degrade titin; these alterations would decrease titin stiffness
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signalling pathways relevant for PKG-mediated titin
phosphorylation.
Disulfide bridge formation in the cardiac titin N2-Bus
A direct oxidative stress-related modification of titin,
which increases cardiomyocyte stiffness, is disulfide
bonding in the cardiac-specific N2-Bus (Fig. 2b). Under
oxidizing conditions, the six conserved cysteines present
in the human N2-Bus can form up to three S–S bridges
(Gru¨tzner et al. 2009). The disordered N2-Bus is thus
mechanically stabilized and its extensibility is greatly
impaired, as shown by single-molecule force-extension
experiments on recombinant N2-B constructs using the
atomic force microscope (AFM) (Gru¨tzner et al. 2009).
Consistent with this, the reducing agent, thioredoxin, had
a de-stiffening effect on isolated human cardiomyofibrils
exposed to a cyclic stretch-release protocol (Gru¨tzner
et al. 2009). Moreover, the maximum extension of the
N2-Bus studied ex vivo by immunoelectron microscopy
of stretched rabbit cardiac sarcomeres was only *100 nm
if a reducing agent was excluded from the medium (Linke
et al. 1999), but *200 nm if DTT (1 mM) was present
(Trombita´s et al. 1999). These values are very close to
those measured for the N2-Bus in vitro using AFM force
spectroscopy in the absence and presence of DTT,
respectively (Gru¨tzner et al. 2009). Another aspect is that
disulfide bonding in the N2-Bus most certainly also
interferes with the regulation of titin stiffness by phos-
phorylation of this region. Indeed, it was observed that
the de-stiffening effect of PKA on isolated cardiac myo-
fibrils, which is caused by phosphorylation of the N2-Bus,
is more pronounced in the presence of DTT than in the
absence of it (Kru¨ger and Linke 2006).
S–S bridge formation in titin’s N2-Bus may not only
have a mechanical effect on the cardiomyocyte, but could
also modify intracellular signalling pathways intersecting
with the N2-Bus (Kru¨ger and Linke 2011). This cardiac
titin region binds the four-and-a-half LIM-domain proteins,
FHL1 and FHL2 (Lange et al. 2002; Sheikh et al. 2008),
and the small heat shock proteins (sHSPs), aB-crystallin
and HSP27 (Bullard et al. 2004; Ko¨tter et al. 2014).
Disulfide bonds in the N2-Bus could alter these interactions
and thus affect pathways of mechanosensation and protein
quality control in the cardiomyocyte (Linke and Hamdani
2014). In conclusion, the N2-Bus of cardiac titin is a pre-
ferred target of oxidative modification in vitro and proba-
bly also in isolated cardiomyocytes. It remains to be
established whether S–S bonding in the N2-Bus occurs
under oxidative stress in vivo and if so, what impact this
modification may have on myocardial stiffness and
mechanical signalling.
S-glutathionylation of cryptic cysteines in the Ig-
domains of I-band titin
A recently elucidated direct modification of titin under
oxidative stress is the S-glutathionylation of cryptic cys-
teines in the Ig-domains of the elastic I-band region (Al-
egre-Cebollada et al. 2014) (Fig. 2c). These cysteines are
usually buried inside the Ig-domain fold but become
exposed if the Ig-domain unfolds. Out of the maximally 93
Ig-domains present in the I-band titin spring, 89 domains
contain cryptic cysteines that can potentially be oxidized
upon domain unfolding. Interestingly, the I-band Ig-
domains of titin contain, on average, between two and three
cysteines, whereas most Ig-domains in all other parts of the
titin molecule contain only one cysteine (Alegre-Cebollada
et al. 2014). The majority of cysteines in the I-band Ig-
domains are evolutionary well conserved. Some of these
cysteines were suggested earlier to form disulfide bridges
under oxidizing conditions, with the proximal and middle
Ig-domains being a potential hotspot for such modifications
(Mayans et al. 2001). However, single-molecule mechan-
ical measurements by AFM force-clamp, using Ig-domain
I91 (nomenclature of Bang et al. 2001), revealed that the
two buried cysteines contained within this domain usually
form mixed disulfides with glutathione in the presence of
GSSG—but only if the domain is unfolded (Alegre-Ce-
bollada et al. 2014) (Fig. 2c). The S-glutathionylation
decreased the mechanical stability of the domain and pre-
vented domain refolding. Importantly, to inhibit domain
refolding, GSSG needed to be exposed for several tens of
seconds, whereas exposure for only a few seconds had no
or little effect. Treatment with reduced glutathione (GSH)
or removal of the two cysteines by site-directed mutagen-
esis restored the ability of the Ig-domain to refold in the
AFM experiments. Furthermore, S-glutathionylation of the
unfolded I91 domain in the presence of GSSG was con-
firmed by Western blotting and was found to be fully
reversible with the administration of DTT (Alegre-Cebol-
lada et al. 2014). These findings showed for the first time
that mechanical unfolding can enable oxidative modifica-
tion of titin’s cryptic cysteines, which disrupt the domain
folding/unfolding dynamics and cause sustained but
reversible changes in titin elasticity.
Mechanical experiments on single skinned human
cardiomyocytes demonstrated that oxidation by GSSG
greatly reduces titin-based passive tension if the myocytes
are exposed to the oxidizing agent in an over-stretched
state favouring Ig-domain unfolding (Alegre-Cebollada
et al. 2014). The reduction in cardiomyocyte stiffness is
expected, because the unfolding of an Ig-domain causes a
gain in contour length by *30 nm compared to the folded
state, such that the titin spring becomes longer and more
extensible (Linke and Fernandez 2002). In the absence of
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over-stretch, GSSG still reduced cardiomyocyte stiffness
by some amount (Alegre-Cebollada et al. 2014), due
probably to a number of unfolded Ig-domains present in
I-band titin at physiological sarcomere lengths (Linke and
Fernandez 2002). The reduction in cardiomyocyte stiffness
on GSSG-treatment was reversible with GSH or DTT.
In summary, evidence from in vitro and ex vivo
experiments suggests that S-glutathionylation of cysteines
in unfolded titin Ig-domains could be an important mech-
anism of myocyte stiffness regulation under oxidant stress,
in both the heart and the skeletal muscles. In support of this
notion, increased S-glutathionylation of sarcomere proteins
was found in mouse heart tissue following myocardial
infarction, and among these proteins was titin (Avner et al.
2012; Alegre-Cebollada et al. 2014). Future studies should
explore how important this oxidative modification of titin
is in the context of heart failure or muscle disease and to
what degree it affects titin-based passive stiffness in vivo.
Titin degradation by oxidative/nitrosative stress-
activated proteases
Yet another way by which oxidative/nitrosative stress
could alter titin stiffness is indirectly via activation of
proteases that degrade titin (Fig. 2d). One of these prote-
ases is MMP2, which is abundant in the cardiomyocyte
(Kandasamy et al. 2010) and localizes to various subcel-
lular compartments, including the Z-disk (Ali et al. 2010).
MMP2 cleaved cardiac titin in a concentration-dependent
manner and in rat hearts the titin cleavage was increased
after myocardial I/R injury causing rapid induction of the
highly pro-oxidant ONOO- (Ali et al. 2010). Conversely,
titin degradation induced by I/R damage was diminished by
an MMP inhibitor. Previously, oxidative stress-activated
MMP2 was shown to degrade various sarcomeric targets
next to titin, including TnI, MLC1, and a-actinin (Wang
et al. 2002; Sawicki et al. 2005; Sung et al. 2007). The
MMP2-mediated structural alterations of sarcomeric pro-
teins may be one reason for the reduced myocardial sys-
tolic and diastolic dysfunction observed with I/R injury
(Linke 2010).
The Ca2?-dependent intracellular protease, calpain-1,
also degrades titin in cardiomyocytes, preferentially within
the elastic spring segment, and calpain inhibitors prevent
this degradation (Lim et al. 2004; Barta et al. 2005).
Although there is no evidence for direct activation of cal-
pain-1 by oxidant stress, the protease is thought to be
induced by cardiac I/R damage due to Ca2? overload (In-
serte et al. 2012). This increase in calcium levels through
oxidative stress occurs by various means, especially via
activation/sensitization of the ryanodine receptor Ca2?-
release channels (Allen et al. 2008). Interestingly, in the
presence of Ca2?, calpain-1 binds to titin’s Ig-domain I4 in
the proximal I-band region (titin domain nomenclature of
Bang et al. 2001) where it could be ‘‘stored until further
use’’ in the myocyte (Coulis et al. 2008). A remarkable
observation in this context is that titin is more susceptible
to calpain-1-mediated proteolysis when it is stretched
(Murphy et al. 2006), suggesting that in extended, or per-
haps overstretched, sarcomeres titin is particularly sus-
ceptible to such proteolysis. Taken together, current
evidence suggests that preferential proteolysis of I-band
titin by activation of calpain-1 is an early process in
myocyte injury and that oxidative stress may play a role in
this structural damage.
Proteolytic degradation of the titin spring segment
induced by oxidative stress will decrease the passive
stiffness of the myocytes irreversibly (Fig. 2d). Active
contraction will also be compromised, as the damage to
I-band titin impairs the accurate positioning of the thick
filaments in the middle of the sarcomere and thus, force
generation by actomyosin (Horowits et al. 1986). More-
over, titin is important for the length-dependent activation
of cardiac and skeletal myocytes (Fukuda and Granzier
2005; Mateja et al. 2013) and titin proteolytic damage will
depress this function. Increased oxidative stress and severe
titin degradation can be observed in human ischemic car-
diomyopathy (Hein et al. 1994; Morano et al. 1994), sug-
gesting that a connection exists between these two events,
although a causative relationship remains to be proven.
Considerations on the possible net effect of oxidative
titin modifications on cell stiffness
The various direct and indirect effects of oxidative stress
on titin (Fig. 2) may occur concomitantly with one another,
which would make it unpredictable in which direction they
alter the stiffness of the myocyte. Whereas the titin phos-
phorylation deficit and the disulfide bonding in the N2-Bus
will increase titin-based stiffness, the S-glutathionylation of
cryptic cysteines and the irreversible protease-dependent
titin cleavage will decrease it. Which one of these effects
may be dominating under which physiological or disease
condition in the heart or the skeletal muscles remains to be
seen. Notably, the oxidative modifications directed at the
titin N2-Bus (Fig. 2a, b) can occur in cardiac but not in
skeletal myocytes, because only the former express the N2-
Bus-containing titin isoforms (N2BA, N2B). In contrast,
the protease-mediated titin degradation and the S-glutath-
ionylation of cryptic cysteines in titin Ig-domains can take
place in both cardiac and skeletal muscle. This S-glutath-
ionylation presumably requires increased muscle stretch
(increased cardiac preload) in order to exert a significant
effect on (cardio) myocyte stiffness. Thus, the higher the
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preload on the cardiac chamber filled under oxidative
stress, the more pronounced may be the mechanical
weakening due to oxidized, unfolded titin Ig-domains.
Along the same line, pre-stretch of a skeletal muscle to
long sarcomere length under oxidant conditions may have a
noticeable softening effect on that muscle. One can also
speculate that oxidative stress in conjunction with high
stretch could have a de-stiffening effect on skeletal myo-
cytes but not on cardiomyocytes, because in the latter the
different means of oxidative titin modifications may neu-
tralize one another in their effect on total passive stiffness.
Oxidative stress is often coupled with other important
changes to the intracellular milieu, especially acidosis (e.g.,
during I/R). Both these conditions evoke a protective
response by the myocyte mediated by inducible heat shock
proteins, such as the sHSPs, aB-crystallin and HSP27
(Mymrikov et al. 2011; Larkins et al. 2012). Under oxidant/
acidic stress, these chaperones associate preferentially with
the I-band titin springs in both cardiac and skeletal myo-
cytes (Bullard et al. 2004; Ko¨tter et al. 2014). Importantly,
the titin-sHSP interaction affects titin stiffness. Folded titin
Ig-domains appear to be stabilized mechanically by this
interaction (Bullard et al. 2004), whereas unfolded Ig-
domains are protected from aggregation by sHSP-binding,
which prevents excessive myocyte stiffening (Ko¨tter et al.
2014). Whether this binding of sHSPs would interfere with
the exposure of cryptic cysteines and their S-glutathiony-
lation under oxidizing conditions is unknown. However,
the sHSP-titin binding adds to the complexity of possible
effects of oxidative stress on titin-based stiffness.
Last but not least, oxidative modifications have been
shown to increase the activity of several protein kinases,
including PKA, PKG, PKC, and CaMKII (reviewed by
Steinberg 2013), and to reduce the activity of protein
phosphatases (Wright et al. 2009). Since the phosphoryla-
tion state of I-band titin affects titin-based stiffness (Linke
and Hamdani 2014), any oxidative stress-mediated increase
in kinase activity or reduction in phosphatase activity will
also have an impact on myocyte stiffness. In conclusion,
while oxidative stress seems almost certain to alter titin
stiffness via multiple mechanisms in vivo, the magnitude
and the direction of the stiffness modulation need to be
established in additional studies.
Oxidative titin modification as a potential biomarker
and therapeutic target
Since oxidative stress plays a crucial role in the pathology
of various cardiac and skeletal muscle diseases (see
Introduction), the question arises whether oxidative modi-
fications in titin may be characteristic of some of those
conditions. Interestingly, in Chagas’ disease, which is
caused by Trypanosoma cruzi infection but presents with
severe cardiac symptoms (cardiomegaly, ventricular dila-
tation), the increased oxidative/nitrosative stress associated
with this disease was shown to cause nitration of Ig-repeats
from the cardiac N2B-titin isoform, and the nitrated pep-
tides were detectable in the plasma from a rat model and
from patients (Dihman et al. 2008). The nitrated titin was
also recognized by antibodies from the host’s immune
system and evoked a self-directed immune response
(Dihman et al. 2012). Thus, ROS/RNS-dependent modifi-
cations of titin could indeed serve as biomarkers of specific
forms of cardiac and skeletal muscle disease. In this con-
text, titin has recently been suggested as a specific bio-
marker of DMD detectable in urine samples of affected
patients and in serum samples from the mdx mouse
(Rouillon et al. 2014; Hathout et al. 2014). Since oxidative
stress is an established hallmark of this muscle disease, it
may be worth extending the analysis to oxidated/nitrated
titin peptide species to improve marker specificity.
Oxidative titin modifications could also serve as
potential therapeutic targets in skeletal or heart muscle
diseases associated with myocyte stiffening. While car-
diomyocyte stiffening is well-documented especially in
diastolic heart failure (Linke and Hamdani, 2014), skeletal
muscle fibres can also get stiffer under disease conditions,
e.g., in certain neurological disorders (Olsson et al. 2006;
Mathewson et al. 2014). An interesting treatment option in
heart failure associated with elevated diastolic stiffness
may arise from the fact that oxidative stress modulates the
NO-cGMP-PKG pathway, an important modifier of titin-
based stiffness. In the transition to heart failure, oxidative
stress can be triggered by co-morbidities, such as old age,
renal insufficiency, obesity, diabetes mellitus, or hyper-
tension, all of which can increase ROS/RNS levels (Paulus
and Tscho¨pe 2013). Oxidative stress would reduce NO
bioavailability, block sGC activity, down-regulate cGMP-
PKG signalling, and thus cause hypo-phosphorylation of
titin at the N2-Bus and pathologically increased passive
tension. A (diastolic) heart failure patient may well benefit
from the use of NO donors, inhibitors of cGMP-degrading
enzymes, antioxidants, or other drugs that block the oxi-
dative-stress effects on titin stiffness (Gladden et al. 2014),
in that cardiomyocyte stiffness will be reduced and myo-
cardial diastolic function improved.
Finally, a yet speculative opportunity to help improve
symptoms in some cardiac (and skeletal myopathy?)
patients may involve promoting the oxidative/nitrosative
modification of cysteines in unfolded titin Ig-domains. For
instance, when treating patients or dogs in acute heart
failure with HNO donors (e.g., Angeli’s salt), improve-
ments in both systolic and diastolic mechanical properties
(including diastolic stiffness) were observed (Sabbah et al.
2013; Arcaro et al. 2014). The de-stiffening effect in
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diastole could be due in part to a reduced titin stiffness
resulting from nitrosative modification (S-nitrosylation) of
cysteines in I-band titin Ig-domains, similar to the effect of
S-glutathionylation on these domains (Alegre-Cebollada
et al. 2014). Notably, the HNO donors are considered to
exert their effects independent from cGMP-PKG (and
cAMP-PKA) signalling.
In conclusion, recent evidence suggests that oxidative/
nitrosative stress-related modifications of titin occur in
both cardiac and skeletal myocytes. These modifications
can alter titin-based passive stiffness and perhaps modulate
additional functions of titin. To which degree the oxidative
modifications of the titin springs may be relevant for
myocyte stiffness in striated muscle disease, remains to be
seen. However, oxidative changes in titin have the potential
to serve as biomarkers and become useful drug targets in
specific forms of muscle/heart disease.
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